Rhythm Pharmaceuticals, Inc.
Rhythm Pharmaceuticals, Inc.
Explore linked clinical trials.7 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment | Abnormalities, Multiple, Body Weight, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Froelich syndrome, Imprinting Disorders, Male Urogenital Diseases, Neurobehavioral Manifestations, Neurologic Manifestations, Nutritional and Metabolic Diseases, Overweight, Parkes Weber syndrome, Pathological Conditions, Signs and Symptoms, Prader-Willi syndrome, Signs and Symptoms, Urogenital Abnormalities, Urogenital Diseases, chromosomal disorder, disorder of sexual differentiation, endocrine system disorder, gonadal disorder, gonadal dysgenesis, hereditary disease, hypogonadism, intellectual disability, nervous system disorder, nutritional disorder, obesity disorder, overnutrition | Active, not recruiting | Phase 1 / Phase 2 | 2026-10-09 | NCT06239116 | |
| A Trial of Setmelanotide in Acquired Hypothalamic Obesity | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Froelich syndrome, Male Urogenital Diseases, Urogenital Abnormalities, Urogenital Diseases, disorder of sexual differentiation, endocrine system disorder, gonadal disorder, gonadal dysgenesis, hypogonadism | Active, not recruiting | Phase 3 | 2026-08-10 | NCT05774756 | |
| Real-World Effects of MC4R Agonist Therapy in BBS and Severe Genetic Obesity | Abnormalities, Multiple, Alstrom syndrome, Bardet-Biedl syndrome, Ciliopathies, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Hyperphagia, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, brain disorder, central nervous system disorder, central nervous system malformation, eye disorder, hereditary disease, hereditary motor and sensory neuropathy, hypothalamic disorder, inherited neurodegenerative disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, peripheral nervous system disorder, polyneuropathy, retinitis pigmentosa | Recruiting | Phase 4 | 2026-06-29 | NCT07674290 | |
| A Study of Setmelanotide in Patients With Prader-Willi Syndrome | Abnormalities, Multiple, Body Weight, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hyperphagia, Imprinting Disorders, Neurobehavioral Manifestations, Neurologic Manifestations, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Prader-Willi syndrome, Signs and Symptoms, Signs and Symptoms, Digestive, chromosomal disorder, hereditary disease, intellectual disability, nervous system disorder, nutritional disorder, obesity disorder, overnutrition | Active, not recruiting | Phase 2 | 2026-02-12 | NCT06772597 | |
| A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756) | Congenital Abnormalities, Congenital Cranial Dysinnervation Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Froelich syndrome, Male Urogenital Diseases, Ocular Motility Disorders, Optic Nerve Hypoplasia, Urogenital Abnormalities, Urogenital Diseases, central nervous system malformation, corpus callosum, agenesis of, cranial nerve neuropathy, disorder of sexual differentiation, endocrine system disorder, eye disorder, gonadal disorder, gonadal dysgenesis, hereditary disease, hypogonadism, nervous system disorder, optic nerve disorder, pituitary stalk interruption syndrome, septooptic dysplasia, third cranial nerve disorder | Recruiting | Phase 3 | 2026-02-12 | NCT06760546 | |
| A Long-Term Study of Bivamelagon in Participants With Hypothalamic Obesity (HO) | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Froelich syndrome, Male Urogenital Diseases, Urogenital Abnormalities, Urogenital Diseases, disorder of sexual differentiation, endocrine system disorder, gonadal disorder, gonadal dysgenesis, hypogonadism | Enrolling by invitation | Phase 2 | 2026-02-10 | NCT07156578 | |
| Early Genetic Identification of Obesity | Abnormalities, Multiple, Bardet-Biedl syndrome, Body Weight, Bone Diseases, Developmental, Ciliopathies, Cognition Disorders, Cognitive Dysfunction, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Hyperphagia, Limb Deformities, Congenital, Musculoskeletal Abnormalities, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Pediatric Obesity, Signs and Symptoms, Signs and Symptoms, Digestive, bone disorder, brain disorder, central nervous system disorder, cognitive disorder, dysostosis, eye disorder, hereditary disease, hypothalamic disorder, musculoskeletal system disorder, nervous system disorder, nutritional disorder, obesity disorder, obesity due to pro-opiomelanocortin deficiency, overnutrition, polydactyly, psychiatric disorder, retinal disorder, retinitis pigmentosa, syndactyly, synostosis | Active, not recruiting | Not stated | 2025-09-29 | NCT06239064 |